Key result
In 2014, hypertension treatment predominantly involved older medications (ACEIs 29%, thiazides 24%, ARBs 22%), with 58% of treated patients achieving SBP <140 mmHg and 24% having SBP ≥150 mmHg.
Cross-Sectional
Yes
In 2014, hypertension treatment in the US predominantly relied on older medications from five major classes, with 24% of treated patients remaining poorly controlled (SBP ≥150).
No takes yet. Share an insight, caveat, or question.
Suboptimal control persists with older agents; leaves open whether updated regimens or intensification strategies have improved outcomes since 2014.
Shah et al. (2017) conducted a cross-sectional in Hypertension. Antihypertensive therapies was evaluated on Blood pressure control and type of antihypertensive agents prescribed. In 2014, hypertension treatment predominantly involved older medications (ACEIs 29%, thiazides 24%, ARBs 22%), with 58% of treated patients achieving SBP <140 mmHg and 24% having SBP ≥150 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: